COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,843 Articles (22,553 medRxiv, 8,290 bioRxiv)

Most recent first Previous |  Page 275: Articles 2741-2750  | Next

Complement dysregulation is a predictive and therapeutically amenable feature of long COVID
Baillie, K., Davies, H. E., Keat, S. B. K., Ladell, K., Miners, K. L., Jones, S. A., Mellou, E., Toonen, E. J. M., Price, D. A., Morgan, B. P., Zelek, W. M.
10.1101/2023.10.26.23297597 — Posted: 2023-10-28
Understanding COVID-19 testing behaviour in England through a sociodemographic lens
Bajaj, S., Chen, S., Creswell, R., Naidoo, R., L.-H. Tsui, J., Kolade, O., Nicholson, G., Lehmann, B., A. Hay, J., U.G. Kraemer, M., Aguas, R., A. Donnelly, C., Fowler, T., Hopkins, S., Cantrell, L., Dahal, P., J. White, L., Stepniewska, K., Voysey, M., Lambert, B., EY-Oxford Health Analytics Consortium
10.1101/2023.10.26.23297608 — Posted: 2023-10-28
Mental health conditions and COVID-19 vaccine outcomes: a scoping review
Jia, R., Coupland, C., Vinogradova, Y., Qureshi, N., Turner, E., Vedhara, K.
10.1101/2023.10.27.23297663 — Posted: 2023-10-28
Echocardiographic characterisation in severe Covid-19 with respiratory failure - an observational study.
Isackson, H., Larsson, A., Lipcsey, M., Frithiof, R., Flachskampf, F., Hultstrom, M.
10.1101/2023.10.27.23297666 — Posted: 2023-10-28
ChineseCVD: first-in-world, web-based, Chinese-specific Cardiovascular Risk Calculator incorporating long COVID, COVID-19 vaccination, SGLT2i and PCSK9i treatment effects
Chang, C., Tse, G., Lee, Q., Chou, O. H. I., Lee, T. T. L., Leung, B. K.-h., Ngai, A. L., Khan, A., Wong, W. T., Wai, A. K. C., Chen, K. Y., Liu, T., Zhou, J.
10.1101/2023.10.27.23297656 — Posted: 2023-10-28
Impact of Memory T Cells on SARS-COV-2 Vaccine Response in Hematopoietic Stem Cell Transplant
VanOudenhove, J. J., Liu, Y., Nelakanti, R., Kim, D., Busarello, E., Tijaro Ovalle, N., Qi, Z., Mamillapalli, P., Siddon, A., Bai, Z., Axtmayer, A., Corso, C., Kothari, S., Foss, F., Isufi, I., Tebaldi, T., Gowda, L., Fan, R., Seropian, S., Halene, S.
10.1101/2023.10.26.564259 — Posted: 2023-10-27
Overcoming antibody-resistant SARS-CoV-2 variants with bispecific antibodies constructed using non-neutralizing antibodies
Inoue, T., Yamamoto, Y., Sato, K., Nakamura, Y., Shimizu, Y., Ogawa, M., Onodera, T., Takahashi, Y., Wakita, T., Kaneko, M. K., Fukasawa, M., Kato, Y., Noguchi, K.
10.1101/2023.10.26.564289 — Posted: 2023-10-27
Immune Epitopes of SARS-CoV-2 Spike Protein and Considerations for Universal Vaccine Development
Magazine, N., Zhang, T., Bungwon, A. D., McGee, M. C., Wu, Y., Veggiani, G., Huang, W.
10.1101/2023.10.26.564184 — Posted: 2023-10-27
Cost-effectiveness analysis of COVID-19 booster doses and oral antivirals in the Indo-Pacific
Bilgin, G. M., Munira, S. L., Lokuge, K., Glass, K.
10.1101/2023.10.26.23297613 — Posted: 2023-10-27
Assessing the causal effect of air pollution on risk of SARS-CoV-2 infection
Navaratnam, A. M. D., Beale, S., Boukari, Y., Nguyen, V., Fong, W. L. E., Braithwaite, I., Byrne, T. E., Fragaszy, E., Geismar, C., Kovar, J., Patel, P., Shrotri, M., Yavlinsky, A., Hayward, A., Khreis, H., Aldridge, R. W.
10.1101/2023.10.26.23297598 — Posted: 2023-10-26

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).